M Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Lightcast lands £20m in funding led by ARCH Venture Partners to advance single-cell analysis platform
Lightcast is a life science tools startup that develops a benchtop platform for functional single-cell analysis. Its technology enables researchers to directly measure how individual cells behave, supporting applications such as antibody discovery, cell therapy, and immunology research.
NRG Therapeutics lands £50m Series B led by SV Health Investors to advance neurodegenerative disease therapies
NRG Therapeutics develops oral small-molecule drugs targeting mitochondrial dysfunction, aiming to slow or halt neurodegenerative diseases such as ALS and Parkinson’s through disease-modifying treatments.
TRIMTECH raises £24m seed led by Cambridge Innovation Capital and SV Health Investors to advance neurodegenerative treatments
TRIMTECH Therapeutics develops targeted protein degradation medicines that selectively remove harmful protein aggregates, focusing on neurodegenerative and inflammatory diseases with limited existing treatment options.
- 2(12 months)
- m-ventures.com
- Update Information
More venture news
- 11 Jun 2026
Space ForgeSpace Forge lands £10m from ESA to develop reusable heat shield for return of space-manufactured materials
EquityDeep Tech - 9 Jun 2026
Cordon TechnologiesCordon Technologies secures £1m round from British Design Fund for precision spraying system that helps farmers cut chemical use
EquityAgriculture - 8 Jun 2026
VolteumVolteum raises £2.2m in funding led by Movens Capital to help fleet operators manage electric and diesel vehicles within a single platform
EquityMobility
